EG 427: EG427 Announces New Preclinical Results from Multipl

EG 427: EG427 Announces New Preclinical Results from Multiple Studies of EG110A in Neurogenic Detrusor Overactivity (NDO) and Overactive Bladder (OAB)

EG 427: EG427 Announces New Preclinical Results from Multiple Studies of EG110A in Neurogenic Detrusor Overactivity (NDO) and Overactive Bladder (OAB)

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Paris , France General , France , Sophie Baumont , Philippe Chambon , Cohesion Bureau , Drug Administration , New Preclinical Results , Multiple Studies , Neurogenic Detrusor Overactivity , Overactive Bladder , Chief Executive Officer , Investigational New Drug ,